Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

NRX Pharmaceuticals (NRXP) Shares Outstanding (Weighted Average) (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 12.07% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2025, down 12.07% year-over-year, with the annual reading at $9.4 million for FY2025, 12.07% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $9.4 million at NRX Pharmaceuticals, down from $18.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $18.9 million in Q3 2025, with the low at $4.0 million in Q1 2024.